MicroRNA Market Size, Share And Development By 2027

The global microRNA market size is expected to showcase exponential growth by reaching USD 613.2 million by 2027 while exhibiting a CAGR of 13.4% between 2020 and 2027. This growth is attributable to the increasing prevalence of chronic diseases such as Cancer and the growing focus on adoption of advanced technology in microRNA research across the globe. This information is published by Fortune Business Insights in its latest report. The report further mentions that the market stood at USD 215.4 million in 2019.

MicroRNAs are small non-coding RNA molecules that are extensively found in animals, plants, and some types of viruses. They play a vital role in post-transcriptional and RNA silencing regulation of gene expression. They are finding significant favor in the healthcare industry owing to their benefits in treating and diagnosing chronic ailments such as liver disease, coronary heart disease, and cancer.  

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/microrna-market-101237

Industry Development:

  • May 2019 – Thermo Fisher Scientific announced its partnership with Scinogy for the development of microRNA and other cell and gene therapies. The companies aim to commercialize their novel therapies to strengthen their positions in the global marketplace.

List of the Companies Profiled in the Market:

  • QIAGEN N.V. (Hilden, Germany)
  • Thermo Fisher Scientific (Waltham, U.S.)
  • BioVendor (Brno, Czech Republic)
  • Takara Bio Inc. (Shiga, Japan)
  • Merck KGaA (Darmstadt, Germany)
  • NanoString Technologies, Inc. (Washington, U.S.)
  • Heim Biotek (Seongnam, South Korea)
  • GeneCopoeia, Inc. (Maryland, U.S.)
  • Takara Bio Inc. (Shiga, Japan)
  • Other Prominent Players

Table of Contents:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Overview of Clinical Trials – Key Candidates, Key Companies
      • Clinical Trials: Potential Candidates, miRNA’s as Therapeutic Agents
      • Clinical Trials: Potential Candidates, miRNA’s as Biomarkers & Diagnostics
    • Regulatory Scenario – miRNA Diagnostic & Therapeutic Products
    • Impact of Covid-19 on the Market
    • Key Developments, Mergers, Acquisitions, etc.
  • Global MicroRNA Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Instruments
      • Kits & Reagents
    • Market Analysis, Insights and Forecast – By Application
      • Isolation & Purification
      • Detection & Quantification
      • Disease Diagnostics
      • Others
    • Market Analysis, Insights and Forecast – By End User
      • Pharma & Biotech Companies
      • Academic & Research Institutes
      • Healthcare Facilities
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Rest of the World